Science shows COVID-19 jabs not worth the risk?
We earlier reported on a study on the Pfizer-BioNTech and Moderna clinical “the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated”. That’s 1 in 800. The authors add that “the limited follow up time prevented an analysis of harm-benefit over a longer period”, so these serious adverse events (and others) are plausibly more prevalent. Source.
Since more benign variants are dominant now, it is an opportune time to contrast this with the number needed to be vaccinated to prevent a severe COVID-19 hospitalisation. Thankfully, the UK government has estimated this recently, producing this handy table (source):
Even if we were to bring down the 1/800 figure to 1/4000 or even 1/8000 to account for people suffering from several serious adverse events, and we ignore the fact that serious adverse events beyond the trial reporting thresholds are simply not factored in, it is still quite obviously the case that 800, 4000, or even 8000, are vastly smaller numbers than, say, 706500 or 932500, indicating that at this stage of the pandemic, particularly for the young and healthy, the risks of the jab far outweigh the benefits. It’s not even close.
Okay then.
Extra: Note that even this woeful result still relies on government estimates that may be biased and unrealistic [since pretty much confirmed]. Perhaps the vaccines aren’t even this effective. We have seen several lines of data, including from the same UK government, indicating that the unjabbed are doing better than the jabbed with regards to COVID deaths as well as non-COVID deaths; the phenomenon of negative effectiveness. Of course, if the jabs are negatively effective (within months or even weeks) it would obviously not even be possible for the benefits to outweigh the risks.